{"DataElement":{"publicId":"2188455","version":"1","preferredName":"Agent Aminoglutethimide Administered Status","preferredDefinition":"administration status for the agent aminoglutethimide.","longName":"AGT_AMINOGL_ADM_STAT","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2762083","version":"1","preferredName":"Agent Aminoglutethimide Administered","preferredDefinition":"the administration of aminoglutethimide, a synthetic derivative of the sedative and anticonvulsant glutethimide with anti-steroid properties.","longName":"AGT_AMGLT_ADM","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2223333","version":"1","preferredName":"Agent","preferredDefinition":"An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect. (NCI)","longName":"C1708","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Agent","conceptCode":"C1708","definition":"An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F62B10F2-76A7-2830-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-02","endDate":null,"createdBy":"UMLLOADER","dateCreated":"2005-05-02","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2762081","version":"1","preferredName":"Aminoglutethimide Administered","preferredDefinition":"A synthetic derivative of the sedative and anticonvulsant glutethimide with anti-steroid properties.  Originally used as an anticonvulsant, aminoglutethimide also blocks adrenal steroidogenesis by inhibiting the enzymatic conversion of cholesterol to pregnenolone.  In addition, this agent blocks the peripheral aromatization of androgenic precursors to estrogens.  Aminoglutethimide does not suppress ovarian estrogen production.:Given.","longName":"C233:C25382","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Aminoglutethimide","conceptCode":"C233","definition":"A synthetic derivative of the sedative and anticonvulsant glutethimide with anti-steroid properties.  Originally used as an anticonvulsant, aminoglutethimide also blocks adrenal steroidogenesis by inhibiting the enzymatic conversion of cholesterol to pregnenolone.  In addition, this agent blocks the peripheral aromatization of androgenic precursors to estrogens.  Aminoglutethimide does not suppress ovarian estrogen production.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Administered","conceptCode":"C25382","definition":"The act of having given something (e.g., a medication or test).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"50F8A62E-3ED8-3DE2-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-07-01","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-07-01","modifiedBy":"ONEDATA","dateModified":"2008-07-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"50F8A62E-3EE9-3DE2-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-02-06","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-07-01","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Use caBIG NCIt based OC instead. - dw","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2188454","version":"1","preferredName":"Aminoglutethimide Administered Status","preferredDefinition":"administration status for the agent aminoglutethimide.","longName":"AMINOGL_ADM_STAT","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"20","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"2575365","version":"1","preferredName":"Unknown","longName":"2575365","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F372-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-15","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"MMADDINENI","dateModified":"2024-01-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E449FA5F-0019-2A2B-E034-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"SHIDED","dateCreated":"2004-09-17","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Not taken","valueDescription":"Not taken","ValueMeaning":{"publicId":"2571951","version":"1","preferredName":"Not taken","longName":"2571951","preferredDefinition":"Not taken","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E61C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-09-17","endDate":null,"createdBy":"SHIDED","dateCreated":"2004-09-17","modifiedBy":"SHIDED","dateModified":"2004-09-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E449FA5F-001B-2A2B-E034-0003BA3F9857","beginDate":"2004-09-17","endDate":null,"createdBy":"SHIDED","dateCreated":"2004-09-17","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Initial","valueDescription":"Initial","ValueMeaning":{"publicId":"2567685","version":"1","preferredName":"Initial","longName":"2567685","preferredDefinition":"Preceding all others in time or space or degree.: A short textual account; having provided a short account.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"First","conceptCode":"C25509","definition":"Preceding all others in time or space or degree.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Report","conceptCode":"C25375","definition":"A short textual account; having provided a short account.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D572-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-12-31","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-31","modifiedBy":"REEVESD","dateModified":"2014-07-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E449FA5F-001D-2A2B-E034-0003BA3F9857","beginDate":"2003-12-31","endDate":null,"createdBy":"SHIDED","dateCreated":"2004-09-17","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Second line","valueDescription":"Second line","ValueMeaning":{"publicId":"2571952","version":"1","preferredName":"Second line","longName":"2571952","preferredDefinition":"Second line","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E61D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-09-17","endDate":null,"createdBy":"SHIDED","dateCreated":"2004-09-17","modifiedBy":"SHIDED","dateModified":"2004-09-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E449FA5F-001F-2A2B-E034-0003BA3F9857","beginDate":"2004-09-17","endDate":null,"createdBy":"SHIDED","dateCreated":"2004-09-17","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Third line","valueDescription":"Third line","ValueMeaning":{"publicId":"2571954","version":"1","preferredName":"Third line","longName":"2571954","preferredDefinition":"Third line","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E61F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-09-17","endDate":null,"createdBy":"SHIDED","dateCreated":"2004-09-17","modifiedBy":"SHIDED","dateModified":"2004-09-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E449FA5F-0021-2A2B-E034-0003BA3F9857","beginDate":"2004-09-17","endDate":null,"createdBy":"SHIDED","dateCreated":"2004-09-17","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2184340","version":"1","preferredName":"Status","preferredDefinition":"Status; a condition or state at a particular time.","longName":"Status","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB6C8AC6-20AD-3E75-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2004-05-27","modifiedBy":"SBR","dateModified":"2005-04-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CALGB CRF:Cancer and Leukemia Group B Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E449FB4D-0D03-2899-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-09-17","endDate":null,"createdBy":"SHIDED","dateCreated":"2004-09-17","modifiedBy":"MAESKEB","dateModified":"2011-11-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811910","version":"1","longName":"Prostate","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811963","version":"1","longName":"Treatment","context":"CTEP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"CRF Text","type":"Preferred Question Text","description":"Aminoglutethimide","url":null,"context":"CTEP"}],"origin":"CALGB CRF:Cancer and Leukemia Group B Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E44B1A67-3693-2852-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-09-17","endDate":null,"createdBy":"SHIDED","dateCreated":"2004-09-17","modifiedBy":"CAMPBELB","dateModified":"2008-07-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}